FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And Older
HuffPost
Pfizer said a third shot would restore the effectiveness of its vaccine to about 95%.
The Food and Drug Administration on Wednesday authorized Pfizer-BioNTech COVID-19 booster shots for Americans 65 and older, those with high-risk conditions, and those in workplaces with high exposure risk — but it stopped short of a similar push for the broader population.
“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic,” acting FDA Commissioner Janet Woodcock said in a statement. “This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed.”
The decision undercuts White House efforts to distribute boosters more widely as the highly contagious delta variant continues to spread, instead siding with a federal advisory panel that voted overwhelmingly last week against such a plan.